In multiple myeloma, every relapse shortens treatment options — time matters

Multiple myeloma is a disease in which each relapse can mean fewer available treatment options and a shorter response to therapy. Delays in oncology cost patients not only their health but also time for work and daily life. Early diagnosis and timely access to treatment are critical for prognosis.